This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version    RSS    Subscribe    Unsubscribe    Archive    Media Kit           June 18, 2014

Home     About SGO    Education    Membership    Clinical Practice    Public Policy    Blog    Partnerships    Store

 

Cancer-gene data sharing boosted
Nature
When the U.S. diagnostics giant Myriad Genetics had its legal monopoly on breast-cancer gene testing eliminated one year ago, the company still retained an enormous edge over competitors. A year after the Supreme Court invalidated the patenting of genes, the number of entries for BRCA variants in ClinVar, a public database for clinical genetic data, has grown to around one-third of the number in the Myriad database.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




GENETICS


Utilizing genetic health care professional reduces unnecessary testing, study shows
Medical Xpress
A study published June 12 in Genetics in Medicine shows that counseling from a genetic health care provider before genetic testing educates patients and may help reduce unnecessary procedures. Researchers surveyed 473 patients who had genetic testing for BRCA1 and BRCA2 gene mutations. Among study participants who saw a board-certified geneticist or genetic counselor, almost all recalled having a pre-test discussion, compared to only 59 percent of those who did not. These findings suggest large differences in quality of care across providers who order testing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


MORCELLATION


FDA says more decisions on morcellation coming
Outpatient Surgery
Will morcellation devices used to laparoscopically remove uterine fibroids be recalled or banned? The FDA is convening a meeting next month to take up the topic. The agency issued an advisory in April, discouraging their use because the devices can spread cancerous tissue in women with undetected uterine sarcomas, a condition the agency says may affect as many as 1 in every 350 women. However, proponents of morcellation say the proportion of women with undetected sarcomas is likely closer to 1 in 1,000; that the prognosis is already bleak for those women; and that for everyone else, the alternatives are typically much more dangerous and invasive.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
PRODUCT SHOWCASE
  ChemoFx Improves Ovarian Cancer Outcomes
ChemoFx® provides invaluable information to physicians choosing from 20+ equivalent treatment recommendations without prior knowledge of how individual patients may respond. ChemoFx determines platinum resistance in primary ovarian cancer and demonstrates longer overall survival by 14 months in recurrent ovarian cancer, making it instrumental in improving patient outcomes.
 


OBESITY


Can weight-loss surgery lower cancer risk for the obese?
HealthDay News
Weight-loss surgery may do more than lower the risk of heart problems and improve Type 2 diabetes in obese patients: A new review suggests it may also lower their chances of a cancer diagnosis. Cancer experts in the United States who reviewed the findings were not completely convinced that surgery can reduce cancer risk to that of normal-weight people. But they agreed that obesity raises the risk of certain cancers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


HEALTH POLICY


US health system tops in spending, last in results
Yahoo
The United States health care system has finished dead last-yet again-in a comparison of first-world countries, despite vastly outspending those nations on health services, according to a new study released.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Exceptional Care, Close to Home

21st Century Oncology – the nation’s largest cancer treatment network and global leader in cancer care – providing integrated clinical teams treating patients collaboratively to improve outcomes.
MORE
Lantheus Proven Success
Discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward new breakthrough tools for the diagnosis and management of disease. MORE


SURVIVORSHIP


ACS predicts that cancer survivors will number nearly 19 million by 2024
Oncology Nurse Advisor
The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, according to an updated report by the American Cancer Society (ACS). Even though cancer incidence rates have been decreasing for 10 years, the number of cancer survivors is growing, according to the second edition of Cancer Treatment & Survivorship Facts & Figures, 2014-2015 and an accompanying journal article published in CA: A Cancer Journal for Clinicians. This is the result of increases in cancer diagnoses driven by the aging and growth of the population, as well as the fact that people are living longer with cancer because of earlier cancer detection and more effective treatments.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




OVARIAN CANCER


Combo scores high in ovarian cancer, for now
Medscape (Free login required)
SGO President-Elect Robert L. Coleman, MD, discusses presentations from the 2014 annual meeting of the American Society of Clinical Oncology (ASCO) with Medscape Oncology Insights. Of particular interest were oral presentations looking at the combination of poly-ADP-ribose polymerase (PARP) inhibitors and angiogenesis inhibitors.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



Women's Cancer News
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Jessica Taylor, Senior Medical Editor, 202-684-7169  
Contribute news


Inclusion of advertisements does not constitute SGO endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the Women's Cancer News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

June 11, 2014
June 4, 2014
June 4, 2014
May 21, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063